A prospective real world study on Compound Houttuyniae Mixture used in people of the observation period in close contact with novel coronavirus pneumonia (COVID-19)

Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) Those who have close contact with patients with novel coronavirus pneumonia;
•2) Be over 18 years old (including 18 years old);
•3) Voluntarily sign written informed consent.

•1) According to the researcher's judgment, the diseases that have been or have suffered may affect the patients to participate in the trial;
•2) Those who are allergic to the known ingredients of this medicine;
•3) Pregnant or lactating women;
•4) Patients who have participated in other clinical trials in the past 3 months;
•5) The researcher believes that there is anything unsuitable for enrollment.

发起方

Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine